Baxalta v. Chugai
Patent Infringement Lawsuit
Meeting your
business goals
together
We stand by always ready to provide
optimal strategies for your company
scroll
Topics
& News
NEW
Takanori ABE's article titled "Clinical trials for original drugs fall under experimental use exception" had been published on LSPN Connect.
NEW
Takanori ABE published the article titled "Clinical trials for original drugs fall under experimental use exception".
NEW
Takanori ABE published the article titled "A closer look at Japan’s desirable patent system in the era of COVID-19".
Cases
Nichia Corporation v. Everlight Electronics
U.S. Patent Infringement Lawsuit
Takanori ABE's article titled "Takanori Abe reviews the litigation in Germany over Nichia's patent for a white LED" was cited in PETITION FOR WRIT OF CERTIORARI Nichia Corporation submitted to the U.S. Supreme Court.
Biopharmaceutical Company v. Pharmaceutical Company
AAA Arbitration
Takanori ABE has submitted an expert opinion and testified at the deposition.
Shire v. Japanese Pharmaceutical Company
ABE & PARTNERS represented Shire in M&A Due Diligence.
Mitsubishi Tanabe Pharma v. Nissin Pharmaceutical
Patent Infringement Lawsuit
Resolved by Settlement
Publications
"Utilizing mediation in patent dispute"
Source : Nikkei Newspaper
"Rethinking pay for delay"
Source : AIPPI Congress News
"Abe & Partners makes two promotions"
Source : LSIPR magazine
"Patent Practice to win the competition"
Source : Johokiko
"Special Report, Courageous Challenge from Solo Practice to General Law Firm"（Interview with Takanori ABE)
Source : March 2013, The Lawyers
“International IP
Law Firm of the Year”― ACQ Global Awards
Information
-
＜Caution＞
ABE & PARTNERS has received information that the name of our firm and atrorney from our office have been used to attempt to commit fraud.
If you receive any contact from an unknown person using the name of our office or an attorney from our office, do not respond immediately, but please fully confirm the identity of that person.
In addition, we would greatly appreciate your informing us by using "Contact".